FDA recall, , Moderate risk
Dexcom G7 Continuous Glucose Monitoring System
Lot 1725204004 were designated for destruction because the G7 sensors were not properly sterilized and have an increased risk of skin infection if used.
Summary by Recall Canary from the FDA notice
What happened
DexCom, Inc., of San Diego, California, announced on May 26, 2026, that certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC. Some of the sensors were designated for destruction because they were not properly sterilized and have an increased risk of skin infection if used.
The company began the recall on May 27, 2026, and the FDA added it to the Enforcement Report on June 24, 2026. Dexcom does not have distribution records due to the unauthorized release, but based on App user performance data, some affected sensors have session starts in the United States, and others have session starts in the United States and many other countries.
What to do
If a code on your device is listed below:
- Users with sensors from affected Dexcom G7 lots (1725204004 and 1725069002) should not use those sensors and can call Dexcom Customer Support in the US at 1-844-478-1600 to request replacements.
- More information on how to determine if sensors are from an affected lot and what action to take is available at www.dexcom.com/theft-check.
Is yours affected?
Match the UDI-DI and model/catalog number listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Dexcom G7 sensors
- UDI-DI
- 00386270004109
- 1725204004
- 1725069002
- Model/Catalog number
- STP-AT-012
Recall details
- Company began the recall
- Sold in
Dexcom does not have distribution records for this product due to its unauthorized release. However Dexcom is able to identify sensor session starts for the affected lots through the Dexcom G7 CGM App user performance data. Based on App user performance data, Lot 1725204004 has sensor session starts in the United States. Based on App user performance data, Lot 1725069002 has sensor session starts in the United States and the countries of Australia, Austria, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Israel, Italy, Japan, South Korea, Kuwait, Netherlands, Poland, Portugal, Qatar, Singapore, Spain, Switzerland, Turkey, United Arab Emirates,and the United Kingdom.
- Company
- Dexcom, Inc.San Diego, California
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98968
- Recall number
- Z-2574-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Announced by the company
Company began the recall
Listed on Recall Canary
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Summary updated
